| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/14/2003 | EP1309691A2 Anti-tnf antibodies, compositions, methods and uses |
| 05/14/2003 | EP1309682A2 Tetraspan protein and uses thereof |
| 05/14/2003 | EP1309627A1 Immunotherapy for chronic myelocytic leukemia |
| 05/14/2003 | EP1309615A2 Amniotic apoptosis modulating substances |
| 05/14/2003 | EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 05/14/2003 | EP1309605A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv |
| 05/14/2003 | EP1309603A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
| 05/14/2003 | EP1309597A2 Polymorphs of an epothilone analog |
| 05/14/2003 | EP1309596A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 05/14/2003 | EP1309595A2 Synthesis of (r)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-h-imidazo(1,2-a) imidazol-2-one |
| 05/14/2003 | EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 05/14/2003 | EP1309593A2 Substituted pyrazoles |
| 05/14/2003 | EP1309592A2 Substituted pyrazoles |
| 05/14/2003 | EP1309591A2 Substituted pyrazoles |
| 05/14/2003 | EP1309590A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 05/14/2003 | EP1309589A2 Urea compounds and methods of uses |
| 05/14/2003 | EP1309587A1 Cinnoline compounds |
| 05/14/2003 | EP1309586A1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders |
| 05/14/2003 | EP1309585A2 Novel indole derivatives and their use as medicaments |
| 05/14/2003 | EP1309582A1 Method for the preparation of citalopram |
| 05/14/2003 | EP1309581A1 Method for the preparation of citalopram |
| 05/14/2003 | EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 05/14/2003 | EP1309573A1 Urethane derivatives |
| 05/14/2003 | EP1309571A1 Non-steroidal inflammation inhibitors |
| 05/14/2003 | EP1309566A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 05/14/2003 | EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials |
| 05/14/2003 | EP1309564A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 05/14/2003 | EP1309563A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases |
| 05/14/2003 | EP1309560A1 Pyridine derivatives as inhibitors of p38 |
| 05/14/2003 | EP1309559A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 05/14/2003 | EP1309557A1 Amlodipine hemimaleate |
| 05/14/2003 | EP1309556A1 Amlodipine fumarate |
| 05/14/2003 | EP1309555A1 Process for making amlodipine maleate |
| 05/14/2003 | EP1309554A1 Amide derivative of amlodipine |
| 05/14/2003 | EP1309553A1 New aporphine esters and their use in therapy |
| 05/14/2003 | EP1309552A1 Compounds and inhibitors of phospholipases |
| 05/14/2003 | EP1309551A1 Indoline derivatives as 5ht2c antagonists |
| 05/14/2003 | EP1309549A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia |
| 05/14/2003 | EP1309547A1 Crystalline and pure modafinil, and process of preparing the same |
| 05/14/2003 | EP1309544A1 Compounds acting as melanocortin receptor ligands |
| 05/14/2003 | EP1309532A1 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof |
| 05/14/2003 | EP1309525A2 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries |
| 05/14/2003 | EP1309369A1 Electro-powder |
| 05/14/2003 | EP1309352A1 Antifungal ketoconazole composition for topical use |
| 05/14/2003 | EP1309351A1 Dermatological formulation |
| 05/14/2003 | EP1309349A2 Pharmaceutical composition and method for the treatment of retroviral infections |
| 05/14/2003 | EP1309339A2 Stimulating neutrophil function to treat inflammatory bowel disease |
| 05/14/2003 | EP1309337A2 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage |
| 05/14/2003 | EP1309333A2 Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections |
| 05/14/2003 | EP1309332A2 Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| 05/14/2003 | EP1309331A2 Medicine for fighting against sexual dysfunction |
| 05/14/2003 | EP1309330A1 Photosensitizers with ligand targeting properties for tumor therapy |
| 05/14/2003 | EP1309329A2 Therapeutic combination of a cetp inhibitor and atorvastatin |
| 05/14/2003 | EP1309328A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
| 05/14/2003 | EP1309327A2 Pharmaceutical compositions of estrogenic agents |
| 05/14/2003 | EP1309326A1 A therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives |
| 05/14/2003 | EP1309325A1 Anticonvulsant derivatives useful for the treatment of depression |
| 05/14/2003 | EP1309324A2 Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x |
| 05/14/2003 | EP1309323A2 Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid |
| 05/14/2003 | EP1309322A2 Method of treating neurodegenerative disorders of the retina and optic nerve head |
| 05/14/2003 | EP1309321A1 Compositions and methods for inhibiting islet dysfunction and autoimmune disorders |
| 05/14/2003 | EP1309320A2 Anthelminthic agents for the prevention of parasitic infections in humans and animals ii |
| 05/14/2003 | EP1309319A2 Pharmaceutical, effervescent formulation containing ramipril |
| 05/14/2003 | EP1309317A1 Pharmaceutical compositions comprising amlodipine maleate |
| 05/14/2003 | EP1309316A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 05/14/2003 | EP1309315A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 05/14/2003 | EP1309314A2 Method of making tablets and tablet compositions produced therefrom |
| 05/14/2003 | EP1278743A4 Novel anti-infectives |
| 05/14/2003 | EP1248618A4 Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl |
| 05/14/2003 | EP1246631B1 Method and device for increasing and/or decreasing the concentration of immunomodulatory-active substances in substance mixtures |
| 05/14/2003 | EP1240162B1 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 05/14/2003 | EP1233953B1 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same |
| 05/14/2003 | EP1200434B1 NEW CYTOTOXIC PYRIDO 2,3,4-kl]ACRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
| 05/14/2003 | EP1192170B1 Propargyl phenyl ether a2a receptor agonists |
| 05/14/2003 | EP1192169B1 C-pyrazole a2a receptor agonists |
| 05/14/2003 | EP1180105B1 Substituted aza-oxindole derivatives |
| 05/14/2003 | EP1175157A4 Low molecular weight polymannuronate |
| 05/14/2003 | EP1165595B1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486 |
| 05/14/2003 | EP1140935B1 1,2-annelated quinoline derivatives |
| 05/14/2003 | EP1140905B1 Heteroaromatic amides as inhibitor of factor xa |
| 05/14/2003 | EP1140189B1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
| 05/14/2003 | EP1137399B1 Improvements in or relating to powders |
| 05/14/2003 | EP1112266B1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 05/14/2003 | EP1109790B1 1, 2, 4-triazole-3-thione compounds |
| 05/14/2003 | EP1107967B1 Triazolopyridazine derivatives for enhancing cognition |
| 05/14/2003 | EP1102746B1 Substituted phenylamidines with antithrombotic action |
| 05/14/2003 | EP1068208B1 Azatricyclo[3.3.1.1] decane derivatives and pharmaceutical compositions containing them |
| 05/14/2003 | EP1049463B1 Use of fc101 as an angiogenesis inhibitor for the treatment of cancer and other angiogenic diseases |
| 05/14/2003 | EP1045842B1 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines |
| 05/14/2003 | EP1042317B1 Indole derivatives as PKC-inhiboitors |
| 05/14/2003 | EP1030659B1 Pharmaceutical composition comprising (+)-EPHEDRINE and an H1 receptor antagonist |
| 05/14/2003 | EP1029863B1 Camptothecin derivatives |
| 05/14/2003 | EP1021194B1 New improved formulation for treatment of osteoporosis |
| 05/14/2003 | EP0999856B1 Radiopharmaceuticals for imaging infection and inflammation |
| 05/14/2003 | EP0994714B1 Use of compositions containing the combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine |
| 05/14/2003 | EP0979096B1 Treatment of infarcts through inhibition of nf-kappab |
| 05/14/2003 | EP0975337B1 Fast release compressed tablet of flurbiprofen |
| 05/14/2003 | EP0974352B1 Drugs inhibiting progress of pterygium and postoperative recurrence of the same |
| 05/14/2003 | EP0971915B1 Method for preparing 2-thienylethylamine derivatives |
| 05/14/2003 | EP0971589B1 Process and means for the eradication of fleas in the habitats of small mammals |